Skip to main content
. Author manuscript; available in PMC: 2013 Nov 18.
Published in final edited form as: J Proteome Res. 2011 Jan 4;10(3):10.1021/pr1010873. doi: 10.1021/pr1010873

Figure 4.

Figure 4

TSA-ALM glycan profiling of the LNCAP PSA. A, scan images of background of the TSA lectin microarray (control) and the TSA lectin microarray for LNCAP PSA (right); B, dose-dependent fluorescent signals of the LNCAP PSA for BSL II (●), LTL (■), MAA (▲), PHA-L (▼), SBA (◆), SJA (Inline graphic), and VVA (Inline graphic); C, dose-dependent fluorescent signals of the LNCAP PSA for DBA(●), LcHA(▼), MPA (Inline graphic), PEA (△), and WFA (Inline graphic); D, dose-dependent fluorescent signals of the LNCAP PSA for Jacalin (●), ECA (■), MNA (▲), PHA-E (▼), UDA (◆), and UEA (Inline graphic).